Brain health policy in Europe has long suffered from a structural problem: the people who live with neurological conditions rarely sit at the same table as the officials who design the systems meant to serve them. A Value-Driven Future for Brain Health & Care, an interactive Policy World Café, sets out to correct that imbalance. Held in the context of the Irish Presidency of the Council of the European Union, the event brings together patients, carers, clinicians, researchers, funders and industry representatives for a single working session rather than a series of parallel conversations.
Why the format matters
The World Café model is deliberately different from a conventional conference. Instead of panels delivering conclusions to a passive audience, participants move through facilitated, small-group discussions built around shared challenges. In this case, the four challenge areas are lived experience, prevention, the translation of research into real-world impact, and value-driven care. Each group is asked to produce something concrete: a priority, a recommendation, a point that can be carried forward rather than left in a notebook. That design choice reflects a wider shift in health policymaking across Europe, where co-production with patients and carers is increasingly treated as a requirement rather than a courtesy.
A policy moment, not an isolated event
Timing the café to coincide with the Irish Presidency is significant. Presidency periods give member states a window to push specific health priorities onto the EU agenda, and brain health has been gaining ground as a cross-border concern because neurological and neurodegenerative conditions place rising pressure on health systems, carers and public budgets throughout the continent. By building on recent national and European gatherings rather than starting from scratch, organisers are signalling that this session is meant to consolidate momentum, not generate a one-off talking point. The closing policy dialogue, where table recommendations are presented directly to decision-makers, is the mechanism meant to prevent the usual drift from discussion to inaction.
What "value-driven care" actually means
The phrase can sound abstract, but in health-system terms it refers to organising services around outcomes that matter to patients, rather than around the volume of procedures or appointments delivered. For brain health, that means weighing prevention and early intervention alongside treatment, and asking whether research funding and innovation pipelines are actually reaching patients in usable forms. Researchers, funders and industry representatives sit in the same discussions precisely because the gap between a laboratory finding and a service available in a local clinic is often where progress stalls. Addressing that gap requires alignment between regulators who assess new treatments, funders who finance long-term programmes, and health professionals who deliver care under resource constraints.
The stakes for health-system resilience
Brain conditions - from stroke recovery to dementia and mental health disorders - are among the costliest and most carer-intensive areas of modern healthcare. A more coordinated, people-centred approach does not eliminate those pressures, but it can reduce duplication, improve early detection, and make better use of limited funding. The test for this café, as for any policy exercise of its kind, will be whether the recommendations produced around the tables survive contact with budget cycles, national health plans and the slower machinery of EU-level coordination. That is the gap between a well-run workshop and a lasting change in how brain health is funded and delivered across Ireland and the wider Union.